Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macular Degeneration (Wet AMD)
Clinical trial NCT03668054 · COMPLETED
Trial details
- NCT number
- NCT03668054
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-07
- Primary completion
- 2018-05-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.